EE614 Evaluating the Cost-Effectiveness of CYP2C19 Genetic Testing in Patients Who Have Experienced an Ischaemic Stroke or Transient Ischaemic Attack in England and Wales
Abstract
Authors
J. Carroll A. Sadek C. Lopez Manzano E. Tomlinson C. Cooper H. Jones A. Mumford R. Palmer P. Whiting W. Hollingworth N. Welton